n-cyclopropyl adenosine-5'-carboxamide has been researched along with butaclamol in 1 studies
| Studies (n-cyclopropyl adenosine-5'-carboxamide) | Trials (n-cyclopropyl adenosine-5'-carboxamide) | Recent Studies (post-2010) (n-cyclopropyl adenosine-5'-carboxamide) | Studies (butaclamol) | Trials (butaclamol) | Recent Studies (post-2010) (butaclamol) |
|---|---|---|---|---|---|
| 14 | 0 | 5 | 33 | 0 | 8 |
| Protein | Taxonomy | n-cyclopropyl adenosine-5'-carboxamide (IC50) | butaclamol (IC50) |
|---|---|---|---|
| D(2) dopamine receptor | Homo sapiens (human) | 0.0123 | |
| D | Rattus norvegicus (Norway rat) | 0.002 | |
| D(3) dopamine receptor | Rattus norvegicus (Norway rat) | 0.002 | |
| D(1A) dopamine receptor | Homo sapiens (human) | 0.05 | |
| D(4) dopamine receptor | Homo sapiens (human) | 0.05 | |
| D(1B) dopamine receptor | Homo sapiens (human) | 0.05 | |
| D(1B) dopamine receptor | Rattus norvegicus (Norway rat) | 0.002 | |
| D(4) dopamine receptor | Rattus norvegicus (Norway rat) | 0.002 | |
| D(3) dopamine receptor | Homo sapiens (human) | 0.0139 | |
| D(2) dopamine receptor | Rattus norvegicus (Norway rat) | 0.0053 | |
| Sigma non-opioid intracellular receptor 1 | Homo sapiens (human) | 0.0525 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
1 other study(ies) available for n-cyclopropyl adenosine-5'-carboxamide and butaclamol
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |